Search company, investor...

Octagon Therapeutics

octagontherapeutics.com

Founded Year

2016

Stage

Convertible Note | Alive

Total Raised

$1.45M

Last Raised

$400K | 2 yrs ago

About Octagon Therapeutics

Octagon Therapeutics has developed a drug discovery platform that focuses on the identification of metabolic pathways that power pathogenic bacteria. Using this platform, the company has identified promising small molecule inhibitors of these critical targets in resistant bacteria.

Headquarters Location

700 Main Street

Cambridge, Massachusetts, 02139,

United States

Missing: Octagon Therapeutics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Octagon Therapeutics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Octagon Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Octagon Therapeutics is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

838 items

Octagon Therapeutics Patents

Octagon Therapeutics has filed 1 patent.

The 3 most popular patent topics include:

  • Antibiotics
  • Experimental drugs
  • Hepatotoxins
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/4/2019

Moraxellaceae, Antibiotics, Experimental drugs, Hepatotoxins, Nucleosides

Application

Application Date

10/4/2019

Grant Date

Title

Related Topics

Moraxellaceae, Antibiotics, Experimental drugs, Hepatotoxins, Nucleosides

Status

Application

Latest Octagon Therapeutics News

Octagon Therapeutics’ Research Alliance with Novo Nordisk

Sep 30, 2022

Latham & Watkins represented Octagon Therapeutics in the transaction. Octagon Therapeutics, a preclinical-stage biopharmaceutical company developing targeted medicines for autoimmune disease, has announced the initiation of a […]

Octagon Therapeutics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Octagon Therapeutics Rank

Octagon Therapeutics Frequently Asked Questions (FAQ)

  • When was Octagon Therapeutics founded?

    Octagon Therapeutics was founded in 2016.

  • Where is Octagon Therapeutics's headquarters?

    Octagon Therapeutics's headquarters is located at 700 Main Street, Cambridge.

  • What is Octagon Therapeutics's latest funding round?

    Octagon Therapeutics's latest funding round is Convertible Note.

  • How much did Octagon Therapeutics raise?

    Octagon Therapeutics raised a total of $1.45M.

  • Who are the investors of Octagon Therapeutics?

    Investors of Octagon Therapeutics include Harvard Innovation Labs and MassChallenge.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.